Workflow
中国核酸药物行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan·2024-10-30 12:43

Investment Rating - The report does not explicitly state an investment rating for the nucleic acid drug industry Core Insights - The global nucleic acid drug market has shown significant fluctuations, with a peak in 2021 at approximately 393.68 billion RMB, followed by a sharp decline in 2023 to about 155.83 billion RMB, indicating a -62.36% change from the previous year [24] - The small nucleic acid drug market is projected to grow steadily, with an estimated market size of 779.22 billion RMB by 2028, reflecting a compound annual growth rate (CAGR) of approximately 24.09% from 2027 to 2028 [21] - The mRNA drug market experienced explosive growth in 2021, reaching 3730.28 billion RMB, but is expected to decline significantly in the following years, with projections of 491.83 billion RMB by 2027 [7][21] Summary by Sections Global Nucleic Acid Drug Market Size - The market size in 2019 was 188.16 billion RMB, increasing to 215.19 billion RMB in 2020, and peaking at 3936.82 billion RMB in 2021, before dropping to 1558.28 billion RMB in 2023 [24] - Forecasts suggest a continued decline, with estimates of 1373.56 billion RMB in 2024 and 1194.23 billion RMB in 2025 [24] Sales of Key Drugs - SPINRAZA (Nusinersen) sales in USD were 2,097 million in 2019, decreasing to 1,741.2 million in 2023, with a projected decline to 1,381.72 million by 2028 [25][28] - EXONDYS 51 (eteplirsen) sales in USD increased from 380.7 million in 2019 to 540.58 million in 2023, with a steady growth rate of approximately 9.2% expected in the coming years [29][30] - ONPATTRO (patisiran) sales peaked at 557.61 million in 2022 but are projected to decline to 354.55 million in 2023, with future growth expected to be modest [31][32] Currency Exchange Rate - The USD to RMB exchange rate has fluctuated, with a rate of 6.99 in 2019, decreasing to 7.07 in 2023, and projected to stabilize around 6.85 by 2027 [26][30] Small Nucleic Acid Drug Market - The small nucleic acid drug market size was 184.95 billion RMB in 2019, with a slight decline to 186.35 billion RMB in 2023, but is expected to grow to 194.8 billion RMB by 2028 [33]